CENTER FOR PHARMACOECONOMICS
LIVE

Serial Number

98876461

Owner

Leerink Intermediate Holdings LLC

Attorney

Cynthia J. Walden

First Use Date

Oct 22, 2024

Filing Date

Nov 27, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CENTER FOR PHARMACOECONOMICS Trademark

Serial Number: 98876461 • Registration: 8198440

CENTER FOR PHARMACOECONOMICS is a trademark filed by Leerink Intermediate Holdings LLC on November 27, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Leerink Intermediate Holdings LLC

53 State Street
Boston, MA 02109

Entity Type: 16

Trademark Details

Filing Date

November 27, 2024

Registration Date

March 31, 2026

First Use Anywhere

October 22, 2024

First Use in Commerce

October 22, 2024

Goods & Services

providing a website featuring online non-downloadable content in the nature of instructional videos, related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Providing a website featuring online non-downloadable instructional videos, webinars and podcasts related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Providing a website featuring online non-downloadable instructional videos, webinars and podcasts in the field of finance; Arranging and conducting conferences and events in the field of finance

Business consulting; Business advisory; Business consultation services, namely, business evaluation regarding firms in the biotechnology, pharmaceutical, and health fields for the assessment of the business value of medical and pharmaceutical innovation and technology

Downloadable reports, electronic newsletters and educational materials related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology

Financial services, namely consulting and advising related to financial matters in the biotechnology, pharmaceutical, and health fields for the assessment of the financial value of medical and pharmaceutical innovation and technology; Providing information related to financial matters in the biotechnology, pharmaceutical, and health fields for the assessment of the financial value of medical and pharmaceutical innovation and technology

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 31, 2026 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Mar 31, 2026 R.SR
WITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 3, 2026 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 11, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 11, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 11, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 11, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 11, 2026 CNEA
NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Feb 10, 2026 GAUN
NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Feb 10, 2026 GAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Feb 10, 2026 NAUD
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 28, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 28, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 28, 2026 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 8, 2026 GNFN
FINAL REFUSAL E-MAILED
Jan 8, 2026 GNFR
FINAL REFUSAL WRITTEN
Jan 8, 2026 CNFR
USE AMENDMENT ACCEPTED
Jan 8, 2026 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Nov 26, 2025 AUPC
USE AMENDMENT FILED
Nov 26, 2025 IUAF
TEAS AMENDMENT OF USE RECEIVED
Nov 26, 2025 EAAU
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 26, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 27, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 27, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 27, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 27, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 27, 2025 CNRT
ASSIGNED TO EXAMINER
May 20, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2025 NWOS
NEW APPLICATION ENTERED
Nov 27, 2024 NWAP